
| Serial Number | 98414541 |
| Word Mark | XOLACTA |
| Filing Date | Wednesday, February 21, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, November 25, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 10, 2024 |
| Translation of Words in Mark | The wording "XOLACTA" has no meaning in a foreign language. |
| Goods and Services | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; drug delivery systems in the nature of exosomes for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; exosome-based drug delivery systems for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; exosomes for medical purposes for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; exosomes for therapeutic purposes for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; biological preparations comprising exosomes for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; synthetic peptides for the treatment of internal diseases and wounds for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; exosomes loaded with synthetic peptides for the treatment of internal diseases and wounds caused by cardiovascular, neurological, and inflammatory diseases and disorders, cancer, radiation sickness, and radiotherapy |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 21, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | The Tiny Cargo Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Roanoke, VA 24016 |
| Party Name | The Tiny Cargo Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Roanoke, VA 24016 |
| Event Date | Event Description |
| Wednesday, February 21, 2024 | NEW APPLICATION ENTERED |
| Wednesday, June 26, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 14, 2024 | ASSIGNED TO EXAMINER |
| Thursday, August 22, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, August 22, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, August 22, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 12, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, November 12, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, November 12, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, November 12, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, November 12, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 4, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 10, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 10, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, January 9, 2025 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Friday, May 9, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, May 9, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, May 9, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, June 9, 2025 | OPPOSITION INSTITUTED NO. 999999 |
| Monday, June 9, 2025 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Monday, October 20, 2025 | OPPOSITION DISMISSED NO. 999999 |
| Monday, October 20, 2025 | OPPOSITION TERMINATED NO. 999999 |
| Monday, October 20, 2025 | TTAB RELEASE CASE TO TRADEMARKS |
| Tuesday, November 25, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |